Enterocutaneous fistulas (ECFs) are challenging to manage and associated with high morbidity and mortality. Mortality ranges from 5% to 20%, with sepsis being the leading cause of death. Factors influencing the outcomes of patients with ECF include fistula anatomy, output volumes and patient comorbidities [1,2]. Specialist intestinal failure centres have improved outcomes significantly and have decreased mortality [1,3]. Chapman et al. described the four management principles for ECF as: source control, fluid resuscitation, effluent management and skin protection [4]. Nutrition has also been identified as a keyfactor influencing patient outcomes [1,4]. A high-output ECF (losses >500 ml/day) can result in fluid and electrolyte loss and malnutrition, culminating in intestinal failure [2,5,6]. The gold-standard nutritional support is parenteral nutrition (PN). However, this is associated with significant complications and is resource intensive and expensive [5,7,8].